Cryolife (CRY) 11.99 $CRY
Zacks Investment Ideas feature highlights: Apple Hospitality REIT, Coresite Realty, Brookfield CDA, Mesa Labs and Cryolife
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 8:30AM CDT
Zacks Investment Ideas feature highlights: Apple Hospitality REIT, Coresite Realty, Brookfield CDA, Mesa Labs and Cryolife
APLE: 17.99 (-0.01), COR: 82.60 (-0.50), CRY: 11.99 (+0.11), MLAB: 121.68 (-0.84), BOXC: 22.53 (-0.47)
CryoLife (CRY) Raised to Strong Buy on Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 6:05AM CDT
On Jun 11, Zacks Investment Research raised CryoLife Inc. (CRY) to a Zacks Rank #1 (Strong Buy).
IRMD: 19.88 (-1.47), MASI: 51.66 (-0.44), CRY: 11.99 (+0.11), MLAB: 121.68 (-0.84)
Five Recent Strong Buys In Two Industries
Brian Bolan - ZACKS - Fri Jun 10, 8:32AM CDT
Five Recent Strong Buys In Two Industries
APLE: 17.99 (-0.01), COR: 82.60 (-0.50), CRY: 11.99 (+0.11), MLAB: 121.68 (-0.84), BOXC: 22.53 (-0.47)
Varian Keeps Up the Winning Streak in Turkey, Expands Base
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:39AM CDT
Varian Medical Systems Inc (VAR) is on a roll, winning a string of orders in Turkey.
IRMD: 19.88 (-1.47), MASI: 51.66 (-0.44), VAR: 83.79 (-1.51), CRY: 11.99 (+0.11)
Corindus Vascular Robotics (CVRS) Jumps: Stock Up 8.3%
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:00AM CDT
Corindus Vascular Robotics Inc. (CVRS) was a big mover last session, as the company's shares rose over 8% on the day.
CVRS: 1.43 (-0.18), CRY: 11.99 (+0.11)
Natus Medical Expands Share Repurchase Program by $20M
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:54AM CDT
Natus Medical Inc. (BABY) recently announced an expansion of its share repurchase program, which authorizes it to buy back additional shares worth $20 million by Jun 1, 2017.
BABY: 36.53 (+0.14), MASI: 51.66 (-0.44), EXAC: 25.53 (+0.11), CRY: 11.99 (+0.11)
The Cooper Companies (COO) Beats Q2 Earnings, View Up
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 7:40AM CDT
The Cooper Companies Inc. (COO) reported adjusted earnings of $2.05 in the second quarter of 2016, beating the Zacks Consensus Estimate by 13 cents.
HYH: 32.24 (-0.34), MASI: 51.66 (-0.44), CRY: 11.99 (+0.11), COO: 162.32 (-0.92)
Luminex's ARIES Flu A/B & RSV Assay Now CE-IVD Marked
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 7:04AM CDT
Luminex Corp (LMNX) recently announced the receipt of CE-IVD marking for the ARIES Flu A/B & RSV Assay.
MASI: 51.66 (-0.44), EW: 101.13 (-0.39), LMNX: 20.22 (-0.16), CRY: 11.99 (+0.11)
Inogen (INGN) Introduces Next-Gen Inogen One G4 POC
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 7:15AM CDT
Inogen Inc (INGN) recently launched a next-generation portable oxygen concentrator (POC) -- Inogen One G4.
MASI: 51.66 (-0.44), INGN: 49.22 (-0.24), EXAC: 25.53 (+0.11), CRY: 11.99 (+0.11)
Downgrade Alert for CryoLife (CRY)
Comtex SmarTrend(R) - Fri Apr 29, 3:19AM CDT
CryoLife (NYSE:CRY) was downgraded from Buy to Neutral at Ladenburg today. The stock closed yesterday at $12.19 on volume of 642,000 shares, above average daily volume of 113,000. Potential upside of 12.1% exists for CryoLife, based on a current level of $12.19 and analysts' average consensus price target of $13.67. The stock should discover initial support at its 50-day moving average (MA) of $11.12 and subsequent support at its 200-day MA of $10.45.
CRY: 11.99 (+0.11)
CryoLife Reports First Quarter 2016 Financial Results
PR Newswire - Wed Apr 27, 4:34PM CDT
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today its results for the first quarter of 2016.
CRY: 11.99 (+0.11)
Shares of CRY Up 20.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Apr 21, 1:28AM CDT
SmarTrend identified an Uptrend for CryoLife (NYSE:CRY) on February 23rd, 2016 at $10.41. In approximately 2 months, CryoLife has returned 20.08% as of today's recent price of $12.50.
CRY: 11.99 (+0.11)
Over 70% of Americans Would Buy A Health Tracking Device if Clinically Accurate
ACCESSWIRE - Wed Apr 20, 7:00AM CDT
REDONDO BEACH, CA / ACCESSWIRE / April 20, 2016 / More than eight in ten consumers believe that tracking their own health data with a clinically accurate monitoring device will help improve their overall health, while over 70% of adults would use a personal monitoring device if it were clinically accurate, according to a survey commissioned by Biotricity Inc. (OTCQB: BTCY) and the Society for Participatory Medicine.
FIT: 13.82 (-0.28), CSII: 18.24 (-0.12), MDT: 85.70 (unch), BEAT: 16.62 (-0.07), CRY: 11.99 (+0.11), AAPL: 97.34 (-1.49)
CryoLife Exercises Right to Acquire PhotoFix(TM) Bovine Pericardium Patch from Genesee BioMedical
PR Newswire - Thu Apr 14, 5:40AM CDT
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it has exercised its right to acquire the PhotoFix(TM) bovine pericardium patch ("PhotoFix"
from Genesee BioMedical, Inc. for $2.3 million in cash. CryoLife acquired the distribution rights and purchase option for PhotoFix in August 2014.
CRY: 11.99 (+0.11)
Biotricity (BTCY) Capitalizes on Healthcare IoT with Clear Pathway to Commercialization
ACCESSWIRE - Wed Apr 06, 9:58AM CDT
REDONDO BEACH, CA / ACCESSWIRE / April 6, 2016 / Biotricity Inc. (OTCQB: BTCY) is developing remote patient monitoring solutions with a focus on the cardiovascular market. As an Internet of Things play in the healthcare industry, the company is bringing innovative new technologies to an established industry controlled by only a handful of companies. Management's focus on a market with existing billing codes provides a clear pathway to revenue, while its collaborations with researchers could open new doors.
FIT: 13.82 (-0.28), CSII: 18.24 (-0.12), BEAT: 16.62 (-0.07), CRY: 11.99 (+0.11), GOOG: 718.36 (-1.05)
LeMaitre Vascular Acquires ProCol(R) Vascular Bioprosthesis
GlobeNewswire - Fri Mar 18, 1:30PM CDT
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it has acquired the ProCol Vascular Bioprosthesis product line from Hancock Jaffe Laboratories, Inc. for $665,000 plus a three year royalty. Simultaneously, LeMaitre Vascular purchased from CryoLife, Inc. finished goods inventory and other ProCol related assets for $2,035,000.
LMAT: 14.67 (-0.36), CRY: 11.99 (+0.11)
Mazor Robotics Renaissance System Ordered in New Jersey
Zacks Equity Research - Zacks Investment Research - Fri Mar 18, 11:50AM CDT
Mazor Robotics Ltd. (MZOR) recently announced that NJ-based Robert Wood Johnson (RWJ) University Hospital has ordered for its first Renaissance system.
ABMD: 101.77 (-0.76), MZOR: 15.98 (+0.20), LMNX: 20.22 (-0.16), CRY: 11.99 (+0.11)
Intuitive Surgical: FDA OKs da Vinci Xi Single-Site Instruments
Zacks Equity Research - Zacks Investment Research - Thu Mar 17, 9:30AM CDT
Intuitive Surgical (ISRG) recently announced the receipt of FDA approval for its da Vinci Xi Single-Site instruments and accessories.
ISRG: 644.10 (+2.51), ABMD: 101.77 (-0.76), LMNX: 20.22 (-0.16), CRY: 11.99 (+0.11)
Zacks Investment Ideas feature highlights: Apple Hospitality REIT, Coresite Realty, Brookfield CDA, Mesa Labs and Cryolife
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 8:30AM CDT
Zacks Investment Ideas feature highlights: Apple Hospitality REIT, Coresite Realty, Brookfield CDA, Mesa Labs and Cryolife
APLE: 17.99 (-0.01), COR: 82.60 (-0.50), CRY: 11.99 (+0.11), MLAB: 121.68 (-0.84), BOXC: 22.53 (-0.47)
CryoLife (CRY) Raised to Strong Buy on Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 6:05AM CDT
On Jun 11, Zacks Investment Research raised CryoLife Inc. (CRY) to a Zacks Rank #1 (Strong Buy).
IRMD: 19.88 (-1.47), MASI: 51.66 (-0.44), CRY: 11.99 (+0.11), MLAB: 121.68 (-0.84)
Five Recent Strong Buys In Two Industries
Brian Bolan - ZACKS - Fri Jun 10, 8:32AM CDT
Five Recent Strong Buys In Two Industries
APLE: 17.99 (-0.01), COR: 82.60 (-0.50), CRY: 11.99 (+0.11), MLAB: 121.68 (-0.84), BOXC: 22.53 (-0.47)
Varian Keeps Up the Winning Streak in Turkey, Expands Base
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:39AM CDT
Varian Medical Systems Inc (VAR) is on a roll, winning a string of orders in Turkey.
IRMD: 19.88 (-1.47), MASI: 51.66 (-0.44), VAR: 83.79 (-1.51), CRY: 11.99 (+0.11)
Corindus Vascular Robotics (CVRS) Jumps: Stock Up 8.3%
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:00AM CDT
Corindus Vascular Robotics Inc. (CVRS) was a big mover last session, as the company's shares rose over 8% on the day.
CVRS: 1.43 (-0.18), CRY: 11.99 (+0.11)
Natus Medical Expands Share Repurchase Program by $20M
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:54AM CDT
Natus Medical Inc. (BABY) recently announced an expansion of its share repurchase program, which authorizes it to buy back additional shares worth $20 million by Jun 1, 2017.
BABY: 36.53 (+0.14), MASI: 51.66 (-0.44), EXAC: 25.53 (+0.11), CRY: 11.99 (+0.11)
The Cooper Companies (COO) Beats Q2 Earnings, View Up
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 7:40AM CDT
The Cooper Companies Inc. (COO) reported adjusted earnings of $2.05 in the second quarter of 2016, beating the Zacks Consensus Estimate by 13 cents.
HYH: 32.24 (-0.34), MASI: 51.66 (-0.44), CRY: 11.99 (+0.11), COO: 162.32 (-0.92)
Luminex's ARIES Flu A/B & RSV Assay Now CE-IVD Marked
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 7:04AM CDT
Luminex Corp (LMNX) recently announced the receipt of CE-IVD marking for the ARIES Flu A/B & RSV Assay.
MASI: 51.66 (-0.44), EW: 101.13 (-0.39), LMNX: 20.22 (-0.16), CRY: 11.99 (+0.11)
Inogen (INGN) Introduces Next-Gen Inogen One G4 POC
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 7:15AM CDT
Inogen Inc (INGN) recently launched a next-generation portable oxygen concentrator (POC) -- Inogen One G4.
MASI: 51.66 (-0.44), INGN: 49.22 (-0.24), EXAC: 25.53 (+0.11), CRY: 11.99 (+0.11)
Downgrade Alert for CryoLife (CRY)
Comtex SmarTrend(R) - Fri Apr 29, 3:19AM CDT
CryoLife (NYSE:CRY) was downgraded from Buy to Neutral at Ladenburg today. The stock closed yesterday at $12.19 on volume of 642,000 shares, above average daily volume of 113,000. Potential upside of 12.1% exists for CryoLife, based on a current level of $12.19 and analysts' average consensus price target of $13.67. The stock should discover initial support at its 50-day moving average (MA) of $11.12 and subsequent support at its 200-day MA of $10.45.
CRY: 11.99 (+0.11)
CryoLife Reports First Quarter 2016 Financial Results
PR Newswire - Wed Apr 27, 4:34PM CDT
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today its results for the first quarter of 2016.
CRY: 11.99 (+0.11)
Shares of CRY Up 20.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Apr 21, 1:28AM CDT
SmarTrend identified an Uptrend for CryoLife (NYSE:CRY) on February 23rd, 2016 at $10.41. In approximately 2 months, CryoLife has returned 20.08% as of today's recent price of $12.50.
CRY: 11.99 (+0.11)
Over 70% of Americans Would Buy A Health Tracking Device if Clinically Accurate
ACCESSWIRE - Wed Apr 20, 7:00AM CDT
REDONDO BEACH, CA / ACCESSWIRE / April 20, 2016 / More than eight in ten consumers believe that tracking their own health data with a clinically accurate monitoring device will help improve their overall health, while over 70% of adults would use a personal monitoring device if it were clinically accurate, according to a survey commissioned by Biotricity Inc. (OTCQB: BTCY) and the Society for Participatory Medicine.
FIT: 13.82 (-0.28), CSII: 18.24 (-0.12), MDT: 85.70 (unch), BEAT: 16.62 (-0.07), CRY: 11.99 (+0.11), AAPL: 97.34 (-1.49)
CryoLife Exercises Right to Acquire PhotoFix(TM) Bovine Pericardium Patch from Genesee BioMedical
PR Newswire - Thu Apr 14, 5:40AM CDT
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it has exercised its right to acquire the PhotoFix(TM) bovine pericardium patch ("PhotoFix"
from Genesee BioMedical, Inc. for $2.3 million in cash. CryoLife acquired the distribution rights and purchase option for PhotoFix in August 2014. CRY: 11.99 (+0.11)
Biotricity (BTCY) Capitalizes on Healthcare IoT with Clear Pathway to Commercialization
ACCESSWIRE - Wed Apr 06, 9:58AM CDT
REDONDO BEACH, CA / ACCESSWIRE / April 6, 2016 / Biotricity Inc. (OTCQB: BTCY) is developing remote patient monitoring solutions with a focus on the cardiovascular market. As an Internet of Things play in the healthcare industry, the company is bringing innovative new technologies to an established industry controlled by only a handful of companies. Management's focus on a market with existing billing codes provides a clear pathway to revenue, while its collaborations with researchers could open new doors.
FIT: 13.82 (-0.28), CSII: 18.24 (-0.12), BEAT: 16.62 (-0.07), CRY: 11.99 (+0.11), GOOG: 718.36 (-1.05)
LeMaitre Vascular Acquires ProCol(R) Vascular Bioprosthesis
GlobeNewswire - Fri Mar 18, 1:30PM CDT
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it has acquired the ProCol Vascular Bioprosthesis product line from Hancock Jaffe Laboratories, Inc. for $665,000 plus a three year royalty. Simultaneously, LeMaitre Vascular purchased from CryoLife, Inc. finished goods inventory and other ProCol related assets for $2,035,000.
LMAT: 14.67 (-0.36), CRY: 11.99 (+0.11)
Mazor Robotics Renaissance System Ordered in New Jersey
Zacks Equity Research - Zacks Investment Research - Fri Mar 18, 11:50AM CDT
Mazor Robotics Ltd. (MZOR) recently announced that NJ-based Robert Wood Johnson (RWJ) University Hospital has ordered for its first Renaissance system.
ABMD: 101.77 (-0.76), MZOR: 15.98 (+0.20), LMNX: 20.22 (-0.16), CRY: 11.99 (+0.11)
Intuitive Surgical: FDA OKs da Vinci Xi Single-Site Instruments
Zacks Equity Research - Zacks Investment Research - Thu Mar 17, 9:30AM CDT
Intuitive Surgical (ISRG) recently announced the receipt of FDA approval for its da Vinci Xi Single-Site instruments and accessories.
ISRG: 644.10 (+2.51), ABMD: 101.77 (-0.76), LMNX: 20.22 (-0.16), CRY: 11.99 (+0.11)
